Data / Drug companies / Sodium nitroprusside
Sodium nitroprusside: 14 companies and 19 products in the FDA NDC directory
Sodium nitroprusside is listed in the FDA National Drug Code Directory by 14 companies, with 19 products in commercial distribution. 17 of the products (89.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; injection; injection, solution, concentrate, and the newest product started marketing on December 1, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 14
- Products
- 19
- Generic (ANDA) products
- 17 (89.5%)
- Application numbers
- 11
- Routes
- Intravenous
- Brand names
- Nipride Rtu
- openFDA record search
- api.fda.gov
Companies that list sodium nitroprusside
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Hainan Poly Pharm. Co., Ltd. | 4 | injection, solution; injection, solution, concentrate | Generic drugs (ANDA) | August 13, 2024 |
| Exela Pharma Sciences, LLC | 2 | injection, solution | New drug applications (NDA) | July 20, 2018 |
| Mylan Institutional LLC | 2 | injection, solution, concentrate | Generic drugs (ANDA) | October 5, 2020 |
| Amneal Pharmaceuticals LLC | 1 | injection | Generic drugs (ANDA) | November 7, 2017 |
| Armas Pharmaceuticals Inc. | 1 | injection | Generic drugs (ANDA) | March 27, 2020 |
| Be Pharmaceuticals Inc. | 1 | injection | Generic drugs (ANDA) | July 12, 2021 |
| Caplin Steriles Limited | 1 | injection | Generic drugs (ANDA) | October 29, 2025 |
| Dr. Reddy's Laboratories Inc. | 1 | injection, solution | Generic drugs (ANDA) | December 1, 2025 |
| Dr. Reddy's Laboratories Inc. | 1 | injection, solution | Generic drugs (ANDA) | December 17, 2019 |
| Eugia US LLC | 1 | injection | Generic drugs (ANDA) | December 10, 2020 |
| Meitheal Pharmaceuticals Inc. | 1 | injection, solution | Generic drugs (ANDA) | December 6, 2019 |
| Micro Labs Limited | 1 | injection | Generic drugs (ANDA) | December 30, 2017 |
| Slate Run Pharmaceuticals, LLC | 1 | injection, solution, concentrate | Generic drugs (ANDA) | October 15, 2020 |
| Somerset Therapeutics, LLC | 1 | injection, solution, concentrate | Generic drugs (ANDA) | August 17, 2018 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 8 | 42.1% |
| Injection | 6 | 31.6% |
| Injection, solution, concentrate | 5 | 26.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 17 | 89.5% |
| New drug applications (NDA) | 2 | 10.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Vasodilator | 19 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.